-
1
المؤلفون: Bianca Reijntjes, Mieke van Suijlichem, Jorien M. Woolderink, Marlies Y. Bongers, Nathalie Reesink-Peters, Lasse Paulsen, Pieter J. van der Hurk, Arjan A. Kraayenbrink, Mirjam J.A. Apperloo, Brigitte Slangen, Tineke Schukken, Fokkedien H.M.P. Tummers, Paul J.M. van Kesteren, Judith A.F. Huirne, Dieuwke Boskamp, Gerton Lunter, Geertruida H. de Bock, Marian J.E. Mourits
المساهمون: Obstetrics and gynaecology, APH - Quality of Care, APH - Societal Participation & Health, Amsterdam Reproduction & Development (AR&D), Life Course Epidemiology (LCE), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), Obstetrie & Gynaecologie, MUMC+: MA Medische Staf Obstetrie Gynaecologie (9), RS: GROW - R2 - Basic and Translational Cancer Biology
المصدر: Reijntjes, B, van Suijlichem, M, Woolderink, J M, Bongers, M Y, Reesink-Peters, N, Paulsen, L, van der Hurk, P J, Kraayenbrink, A A, Apperloo, M J A, Slangen, B, Schukken, T, Tummers, F H M P, van Kesteren, P J M, Huirne, J A F, Boskamp, D, Lunter, G, de Bock, G H & Mourits, M J E 2021, ' Recurrence and survival after laparoscopy versus laparotomy without lymphadenectomy in early-stage endometrial cancer : Long-term outcomes of a randomised trial ', Gynecologic Oncology . https://doi.org/10.1016/j.ygyno.2021.12.019
Gynecologic Oncology. Academic Press Inc.
Gynecologic Oncology, 164(2), 265-270. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 164(2), 265-270. Elsevier Scienceمصطلحات موضوعية: Adult, Survival, Endometrial Neoplasms/mortality, CARCINOMA, Endometrioid/mortality, SURGERY, Laparoscopic surgery, Hysterectomy, Disease-Free Survival, Laparoscopy/methods, Endometrial cancer, Recurrence, Laparotomy/methods, 80 and over, Humans, Hysterectomy/methods, Adjuvant, Aged, Neoplasm Staging, Neoplasm Recurrence, Local/epidemiology, Aged, 80 and over, Laparotomy, Local/epidemiology, Radiotherapy, Obstetrics and Gynecology, Lymphadenectomy, Middle Aged, Endometrial Neoplasms, Neoplasm Recurrence, Oncology, Carcinoma, Endometrioid/mortality, Lymph Node Excision, Laparoscopy, Radiotherapy, Adjuvant, Female, Neoplasm Recurrence, Local, Neoplasm Grading, Carcinoma, Endometrioid
وصف الملف: application/pdf
-
2
المؤلفون: Boer, S.M. de, Powell, M.E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P.B., Ledermann, J.A., Khaw, P., Colombo, A., Fyles, A., Baron, M.H., Jurgenliemk-Schulz, I.M., Kitchener, H.C., Nijman, H.W., Wilson, G., Brooks, S., Carinelli, S., Provencher, D., Hanzen, C., Lutgens, L.C.H.W., Smit, V.T.H.B.M., Singh, N., V. do, D'Amico, R., Nout, R.A., Feeney, A., Verhoeven-Adema, K.W., Putter, H., Creutzberg, C.L., PORTEC Study Grp
المساهمون: Targeted Gynaecologic Oncology (TARGON), Translational Immunology Groningen (TRIGR), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
المصدر: Lancet Oncology, 19(3), 295-309. ELSEVIER SCIENCE INC
The Lancet Oncology, 19(3), 295-309
Lancet Oncology, 19, 3, pp. 295-309
Lancet oncology, 19(3), 295-309. Elsevier Science
Lancet Oncology, 19, 295-309مصطلحات موضوعية: Canada, Time Factors, PROGNOSIS, Endometrial Neoplasms/mortality, Paclitaxel, GYNECOLOGIC-ONCOLOGY-GROUP, Carboplatin, CARCINOMA PATIENTS, Gynecologic Surgical Procedures, All institutes and research themes of the Radboud University Medical Center, Risk Factors, QUALITY-OF-LIFE, Paclitaxel/administration & dosage, RADIATION-THERAPY, Antineoplastic Combined Chemotherapy Protocols, Humans, RECURRENCE, Aged, Neoplasm Staging, III TRIAL, Gynecologic Surgical Procedures/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Australia, Carboplatin/administration & dosage, Chemoradiotherapy, Adjuvant, Chemoradiotherapy, Adjuvant/adverse effects, Middle Aged, CHEMOTHERAPY, Endometrial Neoplasms, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Europe, Treatment Outcome, STAGE-I, Carcinoma, Endometrioid/mortality, Lymph Node Excision, Female, Radiotherapy, Adjuvant, Dose Fractionation, Radiation, Cisplatin, Neoplasm Grading, Carcinoma, Endometrioid, Cisplatin/administration & dosage, CLINICAL-TRIALS, New Zealand
وصف الملف: application/pdf
-
3
المؤلفون: de Boer, Stephanie M., Powell, Melanie E., Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Petronella B., Ledermann, Jonathan A., Khaw, Pearly, Colombo, Alessandro, Fyles, Anthony, Baron, Marie Helene, Jürgenliemk-Schulz, Ina M., Kitchener, Henry C., Nijman, Hans W., Wilson, Godfrey, Brooks, Susan, Carinelli, Silvestro, Provencher, Diane, Hanzen, Chantal, Lutgens, Ludy C.H.W., Smit, Vincent T.H.B.M., Singh, Naveena, Do, Viet, D'Amico, Romerai, Nout, Remi A., Feeney, Amanda, Verhoeven-Adema, Karen W., Putter, Hein, Creutzberg, Carien L., McCormack, Mary, Whitmarsh, Karen, Allerton, Rozenn, Gregory, Deborah, Symonds, Paul, Hoskin, Peter J., Adusumalli, Madhavi, Anand, Anjana, Wade, Robert, Stewart, Alexandra, Taylor, Wendy, Kruitwagen, Roy F.P.M., Hollema, Harry, Pras, Elizabeth, Snyers, An, Stalpers, Lukas, Jobsen, Jan J., Slot, Annerie, Mens, Jan Willem M., Stam, Tanja C.
المصدر: The Lancet Oncology, 19(3), 295. Lancet Publishing Group
مصطلحات موضوعية: Canada, Time Factors, Endometrial Neoplasms/mortality, Clinical Trial, Phase III, Risk Factors, Paclitaxel/administration & dosage, Journal Article, Humans, Comparative Study, Aged, Neoplasm Staging, Gynecologic Surgical Procedures/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Research Support, Non-U.S. Gov't, Australia, Carboplatin/administration & dosage, Chemoradiotherapy, Adjuvant/adverse effects, Middle Aged, Europe, Multicenter Study, Treatment Outcome, Oncology, Randomized Controlled Trial, Carcinoma, Endometrioid/mortality, Lymph Node Excision, Female, Radiotherapy, Adjuvant, Dose Fractionation, Radiation, Neoplasm Grading, Cisplatin/administration & dosage, New Zealand
وصف الملف: image/pdf
-
4
المؤلفون: de Boer, Stephanie M., Powell, Melanie E., Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Petronella B., Ledermann, Jonathan A., Khaw, Pearly, Colombo, Alessandro, Fyles, Anthony, Baron, Marie Helene, Jürgenliemk-Schulz, Ina M., Kitchener, Henry C., Nijman, Hans W., Wilson, Godfrey, Brooks, Susan, Carinelli, Silvestro, Provencher, Diane, Hanzen, Chantal, Lutgens, Ludy C.H.W., Smit, Vincent T.H.B.M., Singh, Naveena, Do, Viet, D'Amico, Romerai, Nout, Remi A., Feeney, Amanda, Verhoeven-Adema, Karen W., Putter, Hein, Creutzberg, Carien L., McCormack, Mary, Whitmarsh, Karen, Allerton, Rozenn, Gregory, Deborah, Symonds, Paul, Hoskin, Peter J., Adusumalli, Madhavi, Anand, Anjana, Wade, Robert, Stewart, Alexandra, Taylor, Wendy, Kruitwagen, Roy F.P.M., Hollema, Harry, Pras, Elizabeth, Snyers, An, Stalpers, Lukas, Jobsen, Jan J., Slot, Annerie, Mens, Jan Willem M., Stam, Tanja C., PORTEC study group
مصطلحات موضوعية: Canada, Time Factors, Endometrial Neoplasms/mortality, Clinical Trial, Phase III, Risk Factors, Paclitaxel/administration & dosage, Journal Article, Humans, Comparative Study, Aged, Neoplasm Staging, Gynecologic Surgical Procedures/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Research Support, Non-U.S. Gov't, Australia, Carboplatin/administration & dosage, Chemoradiotherapy, Adjuvant/adverse effects, Middle Aged, Europe, Multicenter Study, Treatment Outcome, Oncology, Randomized Controlled Trial, Carcinoma, Endometrioid/mortality, Lymph Node Excision, Female, Radiotherapy, Adjuvant, Dose Fractionation, Radiation, Neoplasm Grading, Cisplatin/administration & dosage, New Zealand
وصف الملف: image/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_____10691::b6d8f5d24912db4bb6b8cf3e549b1ce1
https://dspace.library.uu.nl/handle/1874/363891
Full Text via ClinicalKey